Insider Transactions in Q4 2025 at Sonnet Bio Therapeutics Holdings, Inc. (SONN)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2025
|
Richard T Kenney Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
242,748
-100.0%
|
-
|
|
Dec 02
2025
|
Richard T Kenney Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250,265
+50.0%
|
-
|
|
Dec 02
2025
|
Richard T Kenney Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,891
-19.53%
|
-
|
|
Dec 02
2025
|
Stephen J Mcandrew Chief Business Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,446
-100.0%
|
-
|
|
Dec 02
2025
|
Albert D. Dyrness Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,537
-100.0%
|
-
|
|
Dec 02
2025
|
Nailesh Bhatt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,547
-100.0%
|
-
|
|
Dec 02
2025
|
John K. Cini Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,116
-100.0%
|
-
|
|
Dec 02
2025
|
Raghu Rao Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,356
-100.0%
|
-
|
|
Dec 02
2025
|
Susan Dexter Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,643
-100.0%
|
-
|
|
Dec 02
2025
|
Lori Mc Neill Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,394
-100.0%
|
-
|
|
Dec 02
2025
|
Donald J. Griffith Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,375
-100.0%
|
-
|